William Polvino Named CEO of Bridge Medicines

10:18 EDT 3 Apr 2017 | Xconomy

Drug discovery firm Bridge Medicines has appointed William Polvino CEO. Polvino most recently served as president and CEO of Denmark-based Veloxis Pharmaceuticals (NASDAQ: VELO), and ran Helsinn Therapeutics before that. Bridge, based in New York, launched last October to extend the work of the non-profit Tri-Institutional Therapeutics Discovery Institute. With Polvino’s appointment, Bridge says interim […]

Original Article: William Polvino Named CEO of Bridge Medicines


More From BioPortfolio on "William Polvino Named CEO of Bridge Medicines"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...